16K prolactin induces NF-kappaB activation in pulmonary fibroblasts
in Journal of EndocrinologySearch for other papers by Y Macotela in
Current site
Google Scholar
PubMed
Search for other papers by C Mendoza in
Current site
Google Scholar
PubMed
Search for other papers by AM Corbacho in
Current site
Google Scholar
PubMed
Search for other papers by G Cosio in
Current site
Google Scholar
PubMed
Search for other papers by JP Eiserich in
Current site
Google Scholar
PubMed
Search for other papers by A Zentella in
Current site
Google Scholar
PubMed
Search for other papers by G Martinez de la Escalera in
Current site
Google Scholar
PubMed
Search for other papers by C Clapp in
Current site
Google Scholar
PubMed
The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-kappaB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-kappaB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-kappaB. Finally, treatment with 16K PRL induced the degradation of the NF-kappaB inhibitor kappaB-beta (IkappaB-beta), and such degradation was prevented by blocking IkappaB-beta phosphorylation. Altogether, these results show that 16K PRL activates NF-kappaB nuclear translocation via the phosphorylation and degradation of IkappaB-beta. These findings are consistent with NF-kappaB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 217 | 83 | 6 |
| PDF Downloads | 81 | 27 | 1 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519